Clinical Trial: Post-Marketing Surveillance to Evaluate the Safety and Effectiveness of Zastaprazan Citrate

U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07894939) titled 'Post-Marketing Surveillance to Evaluate the Safety and Effectiveness of Zastaprazan Citrate' on Oct. 19.

Brief Summary: This post-marketing surveillance aims to evaluate the safety and effectiveness of zastaprazan citrate administered in Korean patients receiving the drug in accordance with the approved prescribing information.

Study Start Date: Nov. 02, 2024

Study Type: OBSERVATIONAL

Condition: Erosive Gastroesophageal Reflux Disease

Intervention: DRUG: zastaprazan citrate

There is no treatment allocation in this study. Patients who are prescribed zastaprazan citrate at the discretion of their treating physicians will be enr...